Suprazygomatic Maxillary Nerve Block for Management of Postoperative Pain in Adenotonsillectomy Patients

Launched by ASSIUT UNIVERSITY · Nov 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help manage pain after children have their tonsils and adenoids removed, a surgery known as adenotonsillectomy. The researchers want to see if adding a medication called dexamethasone, which reduces inflammation, to a local anesthetic (bupivacaine) used during a specific nerve block can improve pain relief. This is important because traditional pain relief methods may not work well or can cause side effects in children. The trial will involve 80 children aged 3 to 10 years, and they will be divided into two groups: one group will receive the nerve block with both medications, and the other group will receive just the local anesthetic.

To be eligible for this study, children must be scheduled for the adenotonsillectomy and have good overall health (class I or II according to the American Society of Anesthesiologists). However, children with certain conditions, such as significant health issues or allergies to the medications being tested, will not be able to participate. Throughout the trial, the researchers will assess how well the pain is controlled after surgery and monitor for any side effects. This study aims to find a safer way to manage pain for children after this common procedure, potentially leading to less need for stronger pain medications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Parturient of American Society of Anesthesiologists (ASA) class I or II physical status
• • Children scheduled for tonsillectomy with adenoidectomy
• Exclusion Criteria:
• • Patient's guardian refusal to participate in the study. Children with Behavioural changes; physical or developmental delay; neurological disorder or psychological disorder.
• • Children on sedative or anticonvulsant medication.
• • Bleeding diathesis
• • History of sleep apnea
• • Significant organ dysfunction, cardiac dysrhythmia, congenital heart disease
• • Known allergy to the study drugs.
• • Skin lesions or wounds at the puncture site of the proposed block